INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $131M invested in Infinity Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
22
Reduced
24
Closed
18
Calls
$2.06M
Puts
$1.33M
Net Calls
+$735K
Net Calls Change
+$859K
Top Buyers
| 1 |
BlackRock
New York
|
+$12.1M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.27M |
| 3 |
State Street
Boston,
Massachusetts
|
+$3.99M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.51M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.3M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$8.4M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.33M |
| 3 |
TLP
Tri Locum Partners
New York
|
-$3.91M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.37M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.63M |
